Article
Co-clinical FDG-PET Radiomic Signature in Predicting Response to Neoadjuvant Chemotherapy…
bioRxiv · 2021 · Sudipta Roy
Key facts
| Title | Co-clinical FDG-PET Radiomic Signature in Predicting Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer |
|---|---|
| First author | Sudipta Roy |
| Journal | bioRxiv |
| Published | Jun 12, 2021 |
| DOI | 10.1101/2021.06.11.448077 |
| Devices mentioned | K133226, K163234, K200213 |
| Product codes mentioned | LNH, KPS, LNI, OUO |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1